Sleeping 18 hours a day is not unusual for someone living with cancer, and it almost never has a single cause. The overwhelming sleepiness typically results from several forces acting at once: the tumor itself triggering immune signals that alter brain chemistry, the toll of treatments like chemotherapy and radiation, pain medications that suppress wakefulness, muscle wasting that makes every activity exhausting, and psychological weight that compounds the physical burden. Understanding which of these forces is driving the sleep can matter a great deal, because some are reversible and others are not.
The Difference Between Fatigue and True Sleepiness
People often use “tired” and “sleepy” interchangeably, but in cancer care they point to different problems. Cancer-related fatigue is a persistent, whole-body exhaustion that rest does not fix. Excessive daytime sleepiness, on the other hand, is the inability to stay awake, the kind of drowsiness where your eyes close involuntarily. In practice, the two overlap so heavily that even clinicians struggle to separate them. Specialized sleep testing can help distinguish genuine sleepiness from the subjective feeling of fatigue, but in many cancer patients both are present simultaneously.1PubMed Central. Cancer-related fatigue presenting with excessive daytime sleepiness
A study of cancer patients referred for excessive daytime sleepiness found that daytime fatigue was reported by about 94% and daily napping by about 81%, while roughly 69% met criteria for excessive daytime sleepiness specifically. Many had multiple overlapping conditions, including depression, obstructive sleep apnea, and cancer-related fatigue. In some patients, specialized testing revealed underlying disorders of hypersomnolence, including narcolepsy, that had gone unrecognized.2Sleep and Breathing. Excessive daytime sleepiness in cancer patients The point is that extreme sleepiness in cancer rarely comes from one neat cause. It is almost always multifactorial, which is part of why it can be so hard to treat.
How the Tumor Itself Hijacks the Brain’s Sleep Signals
Even before any treatment begins, many cancer patients are already exhausted. The tumor itself drives this through inflammation. As cancer grows, it triggers the immune system to release signaling molecules called cytokines, and several of these directly act on brain regions that control sleep and wakefulness. Research in animal models has shown that tumors elevate levels of inflammatory cytokines like IL-6 and TNF-α in the bloodstream, and that circulating IL-6 partly mediates the drop in voluntary physical activity that looks, from the outside, like fatigue or sleepiness.3PubMed Central. Inflammation and cancer-related fatigue: Mechanisms, contributing factors, and treatment implications
In human studies, elevated IL-6 levels have been associated with the most severe symptom clusters, where pain, fatigue, depression, and sleep disturbance all travel together. Patients with the highest IL-6 levels and the worst physical performance tended to fall into the group experiencing all four symptoms at once.4PubMed. Association of Inflammatory Cytokines With the Symptom Cluster of Pain, Fatigue, Depression, and Sleep Disturbance in Chinese Patients With Cancer This clustering is not a coincidence. It reflects the fact that inflammatory cytokines do not just cause one symptom; they rewire multiple brain circuits at the same time, creating a constellation of problems that reinforce each other.
Sickness Behavior and Why the Body May Be Doing This on Purpose
There is growing evidence that extreme sleepiness during illness is not just a symptom to be fought but something the immune system actively orchestrates. Cytokines like IL-1β and TNF produced during infection or disease have been shown to inhibit wakefulness-promoting regions of the brain, specifically the dorsal raphe nucleus, while simultaneously activating areas that promote deep non-REM sleep.5PubMed Central. The immunology of sickness metabolism
This is not random collateral damage from inflammation. In animal experiments, disrupting sleep during infection with malaria dramatically impaired survival. Mice engineered to lack a key component of IL-1 signaling in the brain failed to increase their sleep in response to influenza infection, and they died at higher rates as a result.5PubMed Central. The immunology of sickness metabolism In humans, chronic sleep disruption is linked to higher infection rates. The immune system, in other words, may be pushing the body toward sleep because sleep genuinely helps the body fight back. For cancer patients, this means that some of the drowsiness may be the body redirecting energy toward immune defense, even if the result is debilitating for daily life.
What Chemotherapy and Radiation Do to Sleep
Cancer treatments add their own layers of disruption. Among patients undergoing outpatient chemotherapy, roughly 87% rate their sleep quality as “fairly bad” or “very bad.” And the problems are not limited to daytime drowsiness. Nighttime sleep is fragmented, with patients averaging about an hour of wakefulness after initially falling asleep each night. Patients report waking due to medication side effects, the need to urinate, pain, coughing, difficulty breathing, and excessive daytime napping that throws off their nighttime schedule.6PubMed Central. Multidimensional Sleep Health and Sleep Environment Factors in Individuals with Cancer Undergoing Outpatient Chemotherapy
A vicious cycle develops: poor nighttime sleep drives excessive daytime napping, which further disrupts the following night’s sleep, which drives more napping. For someone already dealing with inflammatory fatigue and treatment side effects, this cycle can push total time spent sleeping (or attempting to sleep) toward 18 hours or more per day, even if the actual restorative sleep within those hours is limited.
Radiation to the brain carries its own particular burden. A condition known as somnolence syndrome can emerge several weeks after cranial radiation. In one assessment, about 43% of patients who received brain radiation developed moderate somnolence by weeks 11 to 12 after treatment, and a smaller group experienced severe drowsiness. Sleep architecture itself shifted, with the predominant sleep stage changing in a way that reflects deeper, harder-to-interrupt sleep.7PubMed Central. Comprehensive assessment of Somnolence Syndrome in patients undergoing radiation to the brain This syndrome is temporary in most cases, but while it lasts, patients can be profoundly drowsy for weeks.
The Sedation Stack From Pain and Anxiety Medications
Managing cancer pain usually requires opioid medications, and sedation is one of their most common side effects. Patients frequently describe it as fatigue or tiredness rather than sleepiness, which makes it easy to overlook as a drug effect. Some patients find the sedation so debilitating that they consider stopping pain medication altogether, choosing to endure the pain rather than spend their waking hours in a fog.8PubMed. The management of opioid-related sedation
The problem deepens when opioids are combined with other sedating drugs. Cancer patients frequently take benzodiazepines or similar sedatives for anxiety and insomnia. When these are layered on top of opioids, drowsiness increases further. In a study of cancer patients seen at a palliative care clinic, those taking both opioids and sedatives together reported significantly higher drowsiness scores compared with patients on opioids alone.9PubMed. Concurrent use of opioids with benzodiazepines or nonbenzodiazepine sedatives among patients with cancer referred to an outpatient palliative care clinic Add in antiemetics for nausea, antihistamines for itching, and corticosteroids that disrupt sleep timing, and the cumulative sedative burden of a cancer patient’s medication regimen can be staggering. Each drug alone might cause mild drowsiness. Together, they can tip the balance toward spending most of the day asleep.
Muscle Wasting and the Energy Crisis of Cachexia
Cancer cachexia, the severe wasting of muscle and body weight that affects many patients with advanced disease, contributes to sleepiness in a way that is less obvious than medication side effects but equally powerful. Cachexia is not simply losing weight from eating less. It is a metabolic syndrome driven by inflammation and altered protein balance that causes the body to break down its own muscle tissue.10PubMed Central. From bench to bedside: updates in basic science, translational and clinical research on muscle fatigue in cancer cachexia
The consequences go beyond appearance. Research has shown that cancer cachexia causes profound muscle weakness that is not fully explained by the loss of muscle mass itself. Something about the disease process damages muscle quality in addition to muscle quantity. Even muscles that typically resist fatigue, like the postural muscles that keep you upright in a chair, lose their endurance under severe cachexia.11PubMed Central. Cancer cachexia decreases specific force and accelerates fatigue in limb muscle When walking to the bathroom or sitting up in bed becomes genuinely exhausting at a muscular level, the body’s response is to conserve energy through sleep. Patients experience reduced independence and lower quality of life, and the loss of functional capacity makes prolonged rest the path of least resistance.12PubMed Central. Muscle wasting in cancer cachexia: Mechanisms and the role of exercise
When the Body’s Clock Breaks Down
Healthy people have a robust internal clock that consolidates sleep into a single nighttime block and maintains alertness during the day. Cancer can disrupt this circadian rhythm at a fundamental level. The relationship between circadian disruption and cancer is actually bidirectional: disrupted circadian rhythms may promote tumor growth by impairing DNA repair and immune surveillance, and the tumor itself can further disrupt the clock through hormonal fluctuations and immune imbalances.13PubMed Central. The Relationship between Circadian Rhythm and Cancer Disease
When the circadian signal weakens, sleep and wakefulness stop following a predictable pattern. Instead of sleeping for eight hours at night and staying awake for 16, a patient may drift in and out of sleep throughout the 24-hour day. Hospital environments, reduced physical activity, medication timing, and decreased exposure to natural light all compound the problem. From the outside, this fragmented pattern can look like someone who is “sleeping all day,” when what is really happening is that the boundary between sleep and wakefulness has dissolved. The total hours spent asleep may not be as extreme as they appear, but the loss of any consolidated awake time makes it seem as though the person is always sleeping.
Depression, Anxiety, and the Psychological Weight
The psychological burden of cancer intersects with sleepiness in complicated ways. Depression causes hypersomnia in a substantial minority of people who experience it, and depression is extremely common among cancer patients. Anxiety, meanwhile, tends to fragment nighttime sleep, leading to compensatory daytime napping. Studies of patients with advanced cancer have found that they score well above typical cancer-population averages on measures of insomnia, anxiety, depression, and fatigue simultaneously.14PubMed Central. Beta Testing an mHealth Symptom Management Intervention for People With Advanced Cancer
The tricky part is disentangling psychological sleepiness from physical sleepiness. A patient who lies in bed 18 hours a day because they feel too depleted and hopeless to get up is experiencing something different from a patient whose inflammatory cytokines are suppressing wakefulness circuits, even though both look identical to a caregiver watching from the bedside. In practice, most patients experience both, and treating the depression alone, while important, usually does not resolve the sleepiness entirely when the body is also fighting a systemic disease.
Metabolic Disruptions That Quietly Add Up
Cancer can throw off the body’s metabolic balance in ways that promote drowsiness. Liver involvement, whether from primary liver cancer or metastases, can lead to a buildup of toxins in the blood that the liver normally clears. This produces a condition known as hepatic encephalopathy, a neuropsychiatric disorder that changes personality, consciousness, motor function, and cognition, often beginning with subtle drowsiness that progresses to profound sleepiness.15DeckerMed Neurology. Hepatic Encephalopathy, Chronic Hepatic Encephalopathy (Portosystemic Encephalopathy), and Acute Liver Failure
Elevated calcium levels (common in certain cancers), low thyroid function from radiation or immunotherapy, anemia from chemotherapy or bleeding, and kidney impairment can all contribute to drowsiness. Each of these metabolic problems has a specific treatment, which is why they matter so much clinically. A cancer patient sleeping 18 hours a day because of untreated high calcium has a potentially fixable problem. One sleeping 18 hours because of advanced cachexia and widespread disease does not, at least not in the same straightforward way.
Hidden Sleep Disorders That Cancer Unmasks
Some cancer patients were already living with undiagnosed sleep disorders before their cancer diagnosis. Obstructive sleep apnea is common in the general population and even more prevalent in people who are obese, older, or taking medications that relax airway muscles. When cancer piles its own fatigue and sleepiness on top of unrecognized sleep apnea, the result can be extreme.
The encouraging news is that treating the underlying sleep disorder can make a real difference. In a study of cancer patients with obstructive sleep apnea who were recommended positive airway pressure therapy, those who used the device consistently saw a large and meaningful drop in their sleepiness scores, and 17 out of 21 adherent patients who had reported fatigue at baseline said it improved at follow-up.16PubMed Central. Treatment of obstructive sleep apnea with CPAP improves daytime sleepiness and fatigue in cancer patients This is a reminder that not all sleepiness in cancer is caused by the cancer. Some of it is caused by conditions that have well-established treatments, and screening for them is worthwhile even when the patient’s overall prognosis is complicated.
What Can Actually Be Done About It
Given the number of contributing factors, managing extreme sleepiness in cancer usually requires working through them systematically rather than looking for a single fix. The reversible causes are the starting point. Medications can often be adjusted: rotating to a different opioid, reducing sedative overlap, or shifting the timing of corticosteroids away from bedtime. Metabolic problems like high calcium, anemia, or thyroid dysfunction can be treated directly. Undiagnosed sleep apnea can be addressed with breathing devices.
For sleepiness driven by the cancer itself or its treatment, the options are more limited. Light physical activity, even gentle stretching or short walks, has some evidence for improving cancer-related fatigue, partly by reinforcing circadian rhythms and preserving muscle function. Bright light exposure during waking hours can help re-anchor the body clock. Some clinicians trial stimulant medications, though the evidence for their effectiveness in cancer-related drowsiness is mixed and side effects can be a concern.
What often helps caregivers most is understanding why the excessive sleep is happening. When a loved one is sleeping 18 hours a day, it is natural to worry that they are “giving up” or that the sleep itself is somehow harmful. Knowing that the immune system may be actively promoting sleep as part of the body’s defense response, or that medications and metabolic shifts are creating an overwhelming physiological push toward drowsiness, can reframe the experience. The person is not choosing to withdraw. Their body is pulling them into sleep through mechanisms that are, in many cases, stronger than willpower.
When Increasing Sleep Signals a Change in Disease Course
A gradual increase in hours spent sleeping can sometimes signal disease progression, and this is worth discussing plainly. As cancer advances, inflammatory signaling intensifies, organ function declines, nutritional status deteriorates, and the body’s energy reserves shrink. All of these shifts push toward more sleep. In the final weeks and days of life, increasing drowsiness that progresses to longer periods of unconsciousness is a recognized part of the dying process, not a medical emergency.
But an abrupt increase in sleepiness is different and warrants medical attention. A patient who goes from sleeping 10 hours to sleeping 18 over the course of a few days may have a new metabolic problem, a medication interaction, an infection, or a bleed that is affecting the brain. These are situations where rapid evaluation can sometimes identify a treatable cause and restore significant waking time. The distinction between gradual and sudden matters, and caregivers who notice a sharp change should not assume it is simply the disease taking its course without checking.
The Fragmented Night Behind the Long Day
One often-overlooked aspect of sleeping 18 hours a day is how poor the quality of that sleep usually is. Cancer patients who spend enormous amounts of time in bed frequently describe feeling no more rested afterward. Chemotherapy patients average just under seven hours of actual sleep per night despite spending much longer in bed, with roughly an hour of wakefulness scattered throughout the night.6PubMed Central. Multidimensional Sleep Health and Sleep Environment Factors in Individuals with Cancer Undergoing Outpatient Chemotherapy Daytime naps fill some of the gap, but nap sleep tends to be lighter and less restorative than consolidated nighttime sleep.
The result is a paradox that caregivers and patients find deeply frustrating: spending most of the day asleep while never actually feeling rested. The sheer number of hours in bed gives the appearance of oversleeping, but the underlying sleep architecture is broken. Addressing sleep hygiene where possible, keeping the bedroom dark and quiet at night, maintaining some exposure to daylight during waking periods, and timing medications to reduce nighttime awakenings, can sometimes improve the ratio of restorative sleep to total time in bed, even when the total hours cannot be reduced.